The article highlights the potentially game-changing approach of the Company towards treating Alzheimer’s Disease, based on technology developed at Rutgers by Dr. Luciano D’Adamio, PhD, MD, New Jersey ...
15d
Hosted on MSNResearchers make alarming new discovery while investigating side effects of cigarettes — here's what they foundUnderstanding these risks is the first step toward creating a cleaner, safer future. Researchers make alarming new discovery while investigating side effects of cigarettes — here's what they found ...
Gene therapies to treat rheumatoid arthritis have evolved slowly, but one is ready to move into human trials and an osteoarthritis treatment in human trials may have potential for treating RA.
A doctor may prescribe injectable treatments, such as methotrexate, TNF-alpha inhibitors, or interleukin inhibitors, for moderate to severe psoriasis when other treatments don’t work.
11d
GlobalData on MSNBio-Thera signs US deal with Intas for golimumab biosimilarBio-Thera will obtain an upfront payment of $21m and could earn up to $143.5m in development and commercial milestones.
The treatment landscape of Inflammatory Bowel Disease (IBD) has undergone a significant transformation over the past two ...
though the use of tumor necrosis factor-alpha inhibitors may offer protective benefits. Children with rheumatic diseases face heightened risks for severe COVID-19 outcomes, with certain medications ...
Data reinforce dose-dependent mechanism with IMNN-001 100mg/m2 dose associated with 20% increase in IL-12 levels compared to 79mg/m2 dose Results from OVATION 2 Study continue to validate TheraPlas® ...
The following is a summary of “Biomarkers of oxidation, inflammation and intestinal permeability in persons with diabetes ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results